BCL2 and leukemia: Activation of STAT5 promotes cell survival through a Bcl-2-independent mechanism [69], instead of activating Bcl-2, STAT5 can activate the PI3K/AKT/mTOR intracellular signaling pathway and leads to leukemia progression [69,70].